The regime detector flags Early Risk-Off with a score of 0.46/1.0. VIX elevated at 25.50, DXY weakening at 98.73, and credit/liquidity metrics under pressure. The Iran conflict dominates macro headlines with oil crashing -10.2% as G7 discusses emergency reserves. Following the retrospective of March 6 (Grade B-, 27.3% TP1 HR on resolved setups), we prioritize squeeze strategies (best cumulative hit rate) and avoid EU/Asia ETFs (consistent underperformers). Minimum $5B market cap enforced on momentum plays.
Early Risk-Off signals rising volatility and defensive rotation before a full Risk-Off event. The strategy weights shift heavily toward short squeeze (40%) and pre-squeeze (35%) strategies, which have the best cumulative hit rates across our last 3 retrospectives (67% and 45% respectively). Momentum is reduced to 10% weight — only the strongest, large-cap trends survive this regime. We include 20% hedges (TLT, SQQQ) as downside protection.
Curated from 5,826 symbols screened across 4 strategies. Following retro Mar 6 findings: no EU/Asia ETFs (consistent failures), no small-cap momentum (<$5B), cooling-off filter on re-entries. 100% new tickers vs previous scan (Mar 6: XOM, EQNR, RTX, KR, ADM, TTE, GLD, EWY, SH, UNG).
Marvell crushed Q4 earnings with revenue of $2.22B (+22% YoY), driven by custom AI ASICs surging to $1.5B annual run rate. Stock jumped 16% on Mar 6 and now trades at $92.65, just 10% below its 52-week high of $102.77. Q1 guidance of $2.4B signals accelerating AI networking demand. The pre-squeeze thesis: high short interest meeting an AI catalyst wave. MRVL was our best performer in retro #3 (+11.1%) and remains the premier pure-play on custom silicon for hyperscaler AI training.
Novo Nordisk dropped its patent lawsuit and signed a landmark distribution deal — branded Wegovy through the Hims platform at $599/month. This removes a massive legal overhang and transforms HIMS into a GLP-1 distribution powerhouse. The stock surged 40.8% on massive volume (174M shares, ~35x average). At $22.16, HIMS trades at 14.8x forward PE with a $5B market cap. The short squeeze thesis: heavily shorted stock meeting a transformative business catalyst. Healthcare led all sectors today (+4%).
Strait of Hormuz tensions and QatarEnergy production disruptions are tightening global nitrogen supply, lifting CF and fertilizer peers 4-9% in early March. CF hit its 52-week high of $121.80 intraday before pulling back to $111 — a healthy retracement to the 50DMA zone. The stock trades at just 12.4x trailing PE with a 1.7% dividend yield. Energy-adjacent names have been the most reliable sector across all 3 retrospectives. The pullback from highs offers a better entry than chasing the breakout.
FDA decision on orforglipron (oral GLP-1 pill) expected by March 28 via White House fast-track. Phase 3 data showed superiority vs oral semaglutide. LLY at $1,008 trades below its 50DMA ($1,047) after a pullback from the $1,134 high — a textbook momentum retracement entry. With $902B market cap, this is the definitive large-cap healthcare play. Healthcare sector leading all sectors today (+4%). The March 28 FDA binary event provides a clear catalyst window.
Samsara delivered a Q4 earnings blowout: revenue $444M (+28% YoY), EPS $0.18 beating estimates, and ARR hitting $1.89B (+30% YoY). Stock surged 20% on Mar 6, now consolidating at $34.16 after a minor pullback. With $19.7B market cap and strong FY27 guidance, this is a high-quality SaaS breakout. The stock is 50% above its YTD low and 11% above the 50DMA — confirming trend acceleration. Volume on the earnings day was 1.5x average.
Adobe reports Q1 FY2026 earnings on March 12 after close. Street expects EPS $5.88 (+15.8% YoY) on revenue $6.28B (+9.9% YoY), following a strong Q4 beat ($5.50 vs $5.40 est). At $282, ADBE trades at just 10.7x forward PE — its cheapest valuation in a decade — after a 36% drawdown from the $444 high. This is a classic pre-squeeze setup: beaten-down large-cap with a near-term earnings catalyst. Firefly AI monetization and Document Cloud growth could drive a re-rating.
SAP trades 34% below its Feb 2025 high after cloud backlog growth (25%) missed expectations, triggering a steep drawdown. At $200, the stock sits near its 52-week low of $187.94 with a $233B market cap. Guiding cloud revenue +23-25% for 2026 with AI as the top deal driver. This is Europe's largest tech company with enterprise pricing power. The pre-squeeze thesis: oversold large-cap near support with cloud growth re-acceleration potential. SAP is the only EU name in today's scan, chosen specifically because it meets the "truly A+" threshold.
Flight to quality in Early Risk-Off regime. TLT at $89.23 is above both its 50DMA ($88.23) and 200DMA ($88.09), confirming a nascent uptrend. With VIX at 25.50 and Iran conflict escalating, demand for long-duration Treasuries should persist. The 30Y yield is declining (-0.015) while short rates rise, signaling curve steepening that benefits long bonds. TLT is a portfolio hedge, not a return driver — the 20% allocation to hedges is mandated by the Early Risk-Off regime.
Agriculture commodities are entering a stronger cycle phase with soft commodities (coffee, cocoa, sugar) at multi-year highs. DBA at $26.55 trades near its 52-week high of $28.01 with RSI at 68.5 — strong trend but not overbought. Iran conflict disrupting Strait of Hormuz trade routes adds supply chain pressure on agricultural imports. The weak USD (DXY 98.73) is a tailwind for commodity prices. DBA offers uncorrelated exposure to the equity-dominated portfolio.
Mandatory hedge in Early Risk-Off regime (20% allocation). SQQQ provides 3x inverse exposure to the NASDAQ-100, which bounced +1.38% on Friday but remains vulnerable to CPI shock (Thursday), Adobe earnings risk (Tuesday), and geopolitical escalation. VIX at 25.50 supports elevated hedge premium. This is a tactical hedge, not a conviction long — size accordingly (max 5% portfolio). Nikkei -5.2% and DAX -0.77% on Friday signal that Asian and European weakness could spill into US markets Monday.
Today's 10 setups are designed for the Early Risk-Off regime with a CPI-heavy week ahead. The portfolio is split: 60% offensive (squeeze + momentum on high-conviction catalysts) and 40% defensive (TLT, SQQQ, DBA). Average composite score: 87.9/100 with 100% new tickers vs the previous scan.
| Ticker | Strategy | Region | Score | Entry | Stop | TP1 | R/R |
|---|---|---|---|---|---|---|---|
| MRVL | Pre-Squeeze | US | 92 | $90-93 | $84 | $102.77 | 1:1.6 |
| HIMS | Short Squeeze | US | 90 | $21-22.50 | $18.50 | $27 | 1:1.7 |
| CF | Momentum | US | 89 | $108-112 | $100 | $121.80 | 1:1.5 |
| LLY | Momentum | US | 89 | $995-1010 | $960 | $1,060 | 1:1.4 |
| IOT | Breakout | US | 88 | $33-35 | $30 | $40 | 1:1.6 |
| ADBE | Pre-Squeeze | US | 87 | $278-285 | $260 | $310 | 1:1.5 |
| SAP | Pre-Squeeze | EU | 87 | $196-202 | $185 | $220 | 1:1.5 |
| TLT | Safe Haven | ETF | 86 | $88.50-89.50 | $86.50 | $92 | 1:1.2 |
| DBA | Breakout | ETF | 86 | $26.20-26.70 | $25 | $28 | 1:1.2 |
| SQQQ | Short Hedge | ETF | 85 | $69-72 | $62 | $82 | 1:1.5 |
Pre-CPI (Mon-Wed): Enter MRVL, HIMS, CF, IOT, LLY. Watch ADBE for post-earnings entry only if beat. TLT and SQQQ hedges active.
Post-CPI (Thu-Fri): If CPI soft → reduce SQQQ, add to momentum plays. If CPI hot → TLT rallies, SQQQ rallies, trim equity longs.
SAP & DBA: Swing positions with longer horizon, enter on pullbacks to entry zone.
Our scanner analyzes 5,826 symbols across 4 strategies (Short Squeeze, Pre-Squeeze, Breakout, Momentum) with regime-adaptive weighting. The Early Risk-Off regime shifts weights to Short Squeeze (40%) and Pre-Squeeze (35%), based on 6 macro component scores (VIX, SPX, DXY, Credit, Liquidity, TLT).
Following 3 retrospectives (C+ → B+ → B-), we enforce: minimum $5B market cap on momentum plays, no EU/Asia ETFs (consistent underperformers), cooling-off filter on re-entries, 85+ minimum composite score, 20% hedge allocation in Risk-Off, and 2x ATR stops on ETFs.
All 10 entry prices validated against live spot quotes (max 10% deviation). Quote timestamp: 2026-03-09T22:06Z. No stale data. All tickers confirmed tradable with adequate liquidity (>$5M daily volume for stocks, >$1M for ETFs).
Position sizing: max 10% per individual stock, max 5% for leveraged instruments (SQQQ). Portfolio beta managed through TLT (negative equity beta) and DBA (low equity correlation). Average R/R across all setups: 1:1.45.
US: 6 stocks (MRVL, HIMS, CF, LLY, IOT, ADBE). EU: 1 stock (SAP — A+ threshold only). ETFs: 3 (TLT, DBA, SQQQ). No Asia exposure per retro findings (3 consecutive failures). 100% new tickers vs previous scan.
This is NOT financial advice. All setups are for educational and informational purposes only. Past scanner performance does not guarantee future results. The scanner's last retrospective (March 6) scored B- with 27.3% TP1 hit rate on resolved positions. Trading involves substantial risk of loss. Always do your own research, consult a qualified financial advisor, and never invest more than you can afford to lose. Leveraged instruments (SQQQ) carry additional risks including daily rebalancing decay.
Data sources: MarketWatch Gateway (Fintel, ChartExchange, Yahoo Finance, SEC EDGAR), Polymarket, Google Finance. Quotes as of 2026-03-09 22:06 UTC.